Home › Funds › Aegis Wealth Management LLC › DYN

Aegis Wealth Management LLC position in DYN

DYNE THERAPEUTICS INC COM · Health Care

Aegis Wealth Management LLC reported holding 160,030 shares of DYN (DYNE THERAPEUTICS INC COM) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 1.27% of its reported portfolio and ranking #21 among its reported holdings. Aegis Wealth Management LLC has disclosed DYN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)160.03K sh
Reported value held$2.58M
Portfolio Weight1.27%
First reportedQ1 2025
Last changeAdd
Updated2026-11-11

Last updated: 2026-11-11 · Source: SEC EDGAR Form 13F-HR

How Aegis Wealth Management LLC's DYN position evolved

Aegis Wealth Management LLC first disclosed a stake in DYN in Q1 2025 at 33,228 shares (US$348K). The position peaked in Q2 2026 at 150,030 shares, worth US$3.3M. Across 7 filings, Aegis Wealth Management LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 160,030 shares valued at US$2.6M — an increase of 10,000 shares quarter over quarter.. Notable position changes include a 50% increase in Q3 2025 (shares rose 55% over the following quarter), a 52% increase in Q4 2025 (shares fell 7% over the following quarter), a 78% increase in Q1 2026 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 33.23K $347.56K New
Q2 2025 33.23K $347.56K Hold
Q3 2025 49.91K $631.34K Add
Q4 2025 75.91K $1.48M Add
Q1 2026 135.03K $2.45M Add
Q2 2026 150.03K $3.33M Add
Q3 2026 160.03K $2.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DYN and 13F data

DYN (DYNE THERAPEUTICS INC COM) is a Health Care company. 42 other funds we track also report a position in DYN — the largest reported positions include Atlas Venture Life Science Advisors, LLC (US$151.0M), TCG Crossover Management, LLC (US$102.5M), FCPM III SERVICES B.V. (US$85.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DYN

All DYN fund holders →

FAQ

How long has Aegis Wealth Management LLC held DYN?

Aegis Wealth Management LLC has disclosed DYN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Aegis Wealth Management LLC's current position in DYN?

As of Q3 2026, Aegis Wealth Management LLC holds 160.03K shares of DYN (DYNE THERAPEUTICS INC COM), valued at $2.58M, representing 1.27% of its reported portfolio and ranking #21.

Has Aegis Wealth Management LLC been buying or selling DYN?

In the latest 13F filing (Q3 2026), Aegis Wealth Management LLC increased its position in DYN. The position peaked in Q2 2026 at 150.03K shares.

Which other funds hold DYN?

Other major institutional holders of DYN include Atlas Venture Life Science Advisors, LLC, TCG Crossover Management, LLC, FCPM III SERVICES B.V., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.